Clinical Trials Logo

Clinical Trial Summary

This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain. It consists of a short self-administered questionnaire. Relationships between low back pain intensity, maladaptive thoughts and awaited days before ideally requesting a MRI will be evaluated.


Clinical Trial Description

This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain (LBP) and by general practitioners (GP). Literature pointed out that LBP is a common occurrence in people, with high rates of self-resolution in the absence of red flags (i.e. possible indicators of serious spinal pathology). In Italy there is an over-prescription of MRI despite international guidelines go the opposite way. The study consists of a short self-administered questionnaire which will be given to people and GP to complete. In more details, the survey is made of 3 questions collecting information on the limit of tolerance (in days) before requesting (people) and prescribing (GP) a MRI for the lumbar tract of the spinal column. Further, participants will have to complete a self-administered pain intensity numerical rating scale, along with catastrophizing and anxiety self-administered questionnaires. Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample being investigated. Statistical correlations between participants' answers and the scores from the questionnaires will be also evaluated. This study investigates the relationships among acute low back pain, the intention of persons/GP to request/prescribe a MRI despite the absence of red flags, mood disorders and maladaptive thoughts. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06022484
Study type Observational
Source International Institute of Behavioral Medicines
Contact
Status Completed
Phase
Start date September 15, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT00343057 - DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP) N/A
Completed NCT00010985 - Usual Care Vs Choice of Alternative Rx: Low Back Pain Phase 3
Completed NCT00000418 - Psychosocial Treatment for Acute Low Back Pain Phase 2
Completed NCT01708915 - Nonivamide/Nicoboxil Ointment in Acute Low Back Pain Phase 3
Completed NCT00782925 - An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers N/A
Completed NCT04968158 - Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain Phase 3
Completed NCT05001555 - Efficacy and Safety of Dexketoprofen/Vitamin B vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Phase 3
Completed NCT03424707 - A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain Phase 2
Recruiting NCT04328428 - The Evaluation of Single Acupoint Therapy to Acute Low Back Pain N/A
Completed NCT00643383 - A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain Phase 3
Completed NCT02517762 - Acute Low Back Pain: Causes, Mechanisms, Treatment and Followup N/A
Completed NCT04772781 - Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain Phase 2
Completed NCT00706043 - French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire
Completed NCT00525811 - Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression N/A
Completed NCT04575714 - Clinical Pathways and Patients' Attitudes in Acute Low Back Pain
Completed NCT03341832 - Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain Phase 2
Completed NCT00952068 - A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day Phase 2
Completed NCT04082975 - Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain Phase 3
Recruiting NCT02037763 - A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain N/A
Completed NCT01638286 - Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects N/A